1 Coapplication experiments reveal competitive-like functi
2 GABA responses were unaffected when
coapplication lasted only 2 ms.
3 Coapplication of 0.1 to 1% (17-170 mM) ethanol influence
4 In contrast, the
coapplication of 10 microM MK-801 and 300 microM GYKI-52
5 Coapplication of 10(-6) m RPCH and 10(-6) m CabTRP elici
6 Coapplication of 10-100 microM cyclothiazide with glutam
7 ta3gamma2 cDNAs was greatly decreased by the
coapplication of 100 microM LaCl3.
8 ions and that this effect was neutralized by
coapplication of 17-PA with 3alpha5alphaP.
9 We also show that 20 nm TTX or
coapplication of 20 microm RIL + FFA (100-200 microm) st
10 ean +/- S.D.) 7.7 +/- 5% to 192 +/- 52% upon
coapplication of 3 to 300 mM ethanol with 1 to 3 microM
11 C, K53C, and S54C) of 23 functional mutants,
coapplication of 30 microm ATP and 500 nm Ag(+) irrevers
12 Coapplication of 50 muM PYD-106 with a maximally effecti
13 These enhancing effects were reversed by
coapplication of a alpha4beta2-nAChR antagonist, consist
14 Strong activation of PKA in the nerve by
coapplication of a membrane-permeant analog of cAMP and
15 Coapplication of a pharmacologic chaperone and a proteos
16 The
coapplication of a Y5 but not Y1 receptor antagonist eli
17 In addition,
coapplication of ACh and 4BP-TQS results in a further in
18 Conversely,
coapplication of adenosine (10(-6) M) attenuated NMDA re
19 eceptor desensitization was inhibited by the
coapplication of AMPA and cyclothiazide or by the use of
20 Coapplication of an antagonist of metabotropic glutamate
21 autaptic EPSCs was effectively abolished by
coapplication of an antibody to synaptotagmin-1 C2B doma
22 We have shown that intranasal
coapplication of Bacillus anthracis protective Ag (PA) t
23 restored after baclofen treatment by either
coapplication of baclofen and adenosine, or intracellula
24 GABA(A) receptor antagonist bicuculline, and
coapplication of bicuculline and DNQX fully abolished th
25 Coapplication of bisindolylmaleimide V, used as a negati
26 Importantly,
coapplication of diazoxide and CsA exhibited additive ef
27 However, on
coapplication of dopamine reuptake inhibitors with nicot
28 Coapplication of dopamine, however, shows no facilitatin
29 depression could be transformed into LTD by
coapplication of dopamine.
30 Furthermore,
coapplication of Eeyarestatin I and suberanilohydroxamic
31 Coapplication of either 5 microM AMPA or 500 microM aspa
32 Coapplication of either GABA or the competitive antagoni
33 Coapplication of ethanol further increased the ghrelin-i
34 oncentrations of ACh also was increased upon
coapplication of ethanol.
35 The
coapplication of exogenous exendin-4 and, specifically,
36 f alpha1beta2gamma2L GABA-A receptors during
coapplication of GABA and an endogenous neurosteroid (3a
37 ho1A subunit, terminating simultaneously the
coapplication of GABA and picrotoxin induced a large reb
38 Coapplication of GABA or muscimol, but not of gabazine,
39 rate-induced rate change (i) is prevented by
coapplication of GAT1 antagonists, (ii) does not occur i
40 ons of phalloidin and actin were reversed by
coapplication of gelsolin and cytochalasin D, respective
41 e to NPY and any aftereffect were blocked by
coapplication of glutamate receptor antagonists.
42 d not enhance ISO-induced increases in cAMP,
coapplication of ISO and carbachol synergistically activ
43 ression of synaptic transmission elicited by
coapplication of Iso and DCG-IV, while having no signifi
44 Coapplication of kynurenate with glutamate to heteromeri
45 plication of L-732,138, and fully blocked by
coapplication of L-732,138 and SB222200 (an NK3 receptor
46 A brief
coapplication of L-glutamate and MK-801 resulted in a bl
47 Coapplication of low concentrations of DAMGO did not inc
48 In rat hippocampal slices,
coapplication of LY487379 potentiated synaptically evoke
49 of cross-presentation by Ig was inhibited by
coapplication of mannan and, thus, likely to be mediated
50 No further depolarization was seen with
coapplication of maximal glutamate during the maximal iv
51 In cell-pelleting ischemia assays,
coapplication of MCC-134 with diazoxide abolished the ca
52 urrent was rapidly and reversibly blocked by
coapplication of mecamylamine and d-tubocurarine.
53 Coapplication of memantine was associated with recovery
54 Coapplication of menthol with acetylcholine or nicotine
55 We conclude that
coapplication of metformin enhances the glucose-lowering
56 Furthermore, topical
coapplication of MMP13i with gatifloxacin greatly improv
57 We found that
coapplication of NMDA and the mGluR5 agonist (S)-3,5-dih
58 The NMDA-induced phase delay was blocked by
coapplication of NPY (0.02-200 microm).
59 Coapplication of pentobarbital, benzodiazepines, and zol
60 versible, are stereospecific, are blocked by
coapplication of PKC inhibitors, and closely match those
61 Coapplication of representative blockers and openers rev
62 2) and tissue analysis of ATP, we found that
coapplication of rotenone (50 nM), a mitochondrial compl
63 Strikingly,
coapplication of rotenone and succinate also prevented g
64 Coapplication of serine protease inhibitors with the sup
65 versed in the two neuronal subclasses by the
coapplication of the appropriate combination of pharmaco
66 Coapplication of the two agonists at their EC(50) concen
67 BDNF's effects were abolished by
coapplication of the tyrosine kinase inhibitor K252a.
68 In vivo,
coapplication of UV-inactivated MV with NDV led to incre
69 d in the pain model but could be restored by
coapplication of VU0360172 and ACEA.
70 Moreover,
coapplication of Z-VAD-FMK and nifedipine produced virtu
71 apable of opening nonconductive channels and
coapplication of zinc pyrithione and retigabine could re
72 Coapplication of zinc with low concentrations of acetylc
73 stratum corneum, effects largely reversed by
coapplications of cholesterol.
74 Coapplications of n-octanol increased peak currents evok
75 This strategy, termed
coapplication reverse transcription (Co-RT), allows for
76 Coapplication with ACh enhanced the extent of MTS modifi
77 spase-3 activity, which could be reversed by
coapplication with endothelin-1, bFGF, or the adenylate
78 w onset of Con G block could be prevented by
coapplication with high concentrations of NMDA or of the
79 Agonist
coapplication with MTSET reduced the extent and rate of
80 SEA sensitivity was significantly amended by
coapplication with substrates.